JAMP-LACOSAMIDE
Identification of Jamp-Lacosamide
| No description |
Google image searchProduct monograph
Active ingredient
lacosamide, 150 MG
DIN: 02488418
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 06-MAR-2020
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AX — Other antiepileptics (ATC, ATC/DDD)
- N03AX18 — LACOSAMIDE (ATC/DDD)
Reference brand drug: Vimpat
